...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: something. anything.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"Does anyone recall if fthey have attended ASCO in the recent past?"

They attended last year, as indicated on their events page. I don't see anything about 2020 on their events page. Got a link for what you are seeing?

BDAZ

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply